• Dechert has represented a wide variety of clients in securities litigation matters. Among them are:

    • AIG Financial Products
    • American Greetings
    • Bank of America
    • Bank of New York Mellon
    • Bear, Stearns
    • The Boeing Company
    • Continental Resources
    • Delcath Systems
    • Discover Financial Services
    • Endocyte
    • Exide Technologies
    • First Eagle Investment Management
    • GlaxoSmithKline
    • Goodyear Tire and Rubber
    • HSBC
    • JP Morgan Securities
    • Lehman Brothers board of directors
    • Microsoft
    • Morgan Stanley
    • OppenheimerFunds
    • Priceline.com
    • Red Hat
    • Schwab Investments
    • Takata Corporation
    • UBS
  • We represent both major and regional broker-dealers in disputes with customers, predominantly in arbitration forums, as well as controversies between member firms over issues such as the departure of registered representatives.

  • We have extensive experience representing life sciences companies in a broad range of securities litigation matters, including claims arising out of the development, commercialization, sale and marketing of pharmaceutical products.

  • We are a leader in the successful representation of asset managers, banks and other lenders, broker-dealers, commodities and derivatives firms, fund complexes, hedge funds and insurers, along with boards and individual directors. Our litigators have guided financial clients through regulatory and other disputes arising worldwide.

  • Our M&A litigation clients include acquirers, sellers, bidders, corporate officers and directors, special board committees, investment banks and advisers, venture capitalists, individual investors, private equity firms, hedge funds and other stakeholders. We also represent deal parties in inquiries and investigations pursued by the SEC and stock exchanges, as well as in arbitration and other forms of alternative dispute resolution.

  • We represent investment advisers, fund companies, boards and individual trustees, broker-dealers and industry organizations in virtually all types of litigation and enforcement matters. In litigation, we regularly defend fund industry clients in high-stakes matters under a host of federal and state laws and at all levels of the federal and state court systems. We are also on the front lines of defending enforcement investigations and internal investigations, and have decades of experience with the full range of fund-related regulatory proceedings.

  • We defend financial firms, public companies, investment advisers and other institutions subject to oversight and investigation by the SEC and other government agencies. Our long experience — combined with our deep knowledge of the law and industry practices — helps us develop strategies that are both effective and inventive.